Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
MDM Policy & Practice|October 6, 2018
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIVVilija R Joyce, Huiying Sun, Paul G Barnett, et al.
JACC. Heart Failure|June 2, 2018
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic CardiomyopathyDivaka Perera, Tim Clayton, Mark C Petrie, et al.
Discover Health Systems|July 18, 2024
Using economic analysis to inform health resource allocation: lessons from MalawiMegha Rao, Dominic Nkhoma, Sakshi Mohan, et al.
The American Journal of Managed Care|October 21, 2014
Effect of management strategies and clinical status on costs of care for advanced HIVPaul G Barnett, Adam Chow, Vilija R Joyce, et al.
Current Medical Research and Opinion|April 8, 2018
Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysemaRachel Evans, Martin Brutsche, Rachele Busca, et al.
BMJ (Clinical Research Ed.)|January 21, 2010
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgeryMartin Henriksson, Stephen Palmer, Ruoling Chen, et al.
The Journal of Infectious Diseases|April 2, 2016
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan AfricaAndrew N Phillips, Valentina Cambiano, Paul Revill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 20, 2009
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV diseaseVilija R Joyce, Paul G Barnett, Ahmed M Bayoumi, et al.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
MDM Policy & Practice|October 6, 2018
Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIVVilija R Joyce, Huiying Sun, Paul G Barnett, et al.
JACC. Heart Failure|June 2, 2018
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic CardiomyopathyDivaka Perera, Tim Clayton, Mark C Petrie, et al.
Discover Health Systems|July 18, 2024
Using economic analysis to inform health resource allocation: lessons from MalawiMegha Rao, Dominic Nkhoma, Sakshi Mohan, et al.
The American Journal of Managed Care|October 21, 2014
Effect of management strategies and clinical status on costs of care for advanced HIVPaul G Barnett, Adam Chow, Vilija R Joyce, et al.
Current Medical Research and Opinion|April 8, 2018
Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysemaRachel Evans, Martin Brutsche, Rachele Busca, et al.
BMJ (Clinical Research Ed.)|January 21, 2010
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgeryMartin Henriksson, Stephen Palmer, Ruoling Chen, et al.
The Journal of Infectious Diseases|April 2, 2016
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan AfricaAndrew N Phillips, Valentina Cambiano, Paul Revill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 20, 2009
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV diseaseVilija R Joyce, Paul G Barnett, Ahmed M Bayoumi, et al.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Pageof 18